Janux Therapeutics Inc (JANX)

Cash & Equivalents

$27.77M

Quarterly · Period ending: · USD

JANX logo

JANX Cash & Equivalents

Latest reported$27.77M
JANX Quarterly Cash & Equivalents ($7.81M → $27.77M)
High-resolution chart · PNG

JANX cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Janux Therapeutics Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
27,768,000
51,828,000
52,334,000
48,389,000
52,446,000
73,743,000
430,605,000
26,754,000
14,662,000
212,803,000
19,205,000
17,152,000
33,703,000
30,355,000
51,426,000
64,752,000
58,403,000
55,129,000
35,582,000
39,389,000
251,625,000
70,769,000
7,813,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.